The Spectrum of Haemoglobinopathies: A Tertiary Care Hospital Experience
DOI:
https://doi.org/10.70749/ijbr.v3i7.1479Keywords:
Anaemia, Hemoglobinopathies, ThalassemiaAbstract
Background: A scientist, Csaba Harvath first described high-performance chromatography (HPLC). HPLC method is beneficial for detecting different types of hemoglobinopathies, including both quantitative and qualitative disorders of globin chains.This study aimed to explore the significance of HPLC technique in the diagnosis of various hemoglobinopathies. Methods: This cross-sectional retrospective study was conducted in the Central Laboratory of Civil Hospital Karachi from 1st Jan 2021 to 31 Dec 2023. A total of 1464 patients were included who came with low hemoglobin levels. Analysis of blood for complete blood count was done on an XN 1000 analyzer and then HPLC was performed on an Arkray analyzer in samples received in our laboratory. Hemoglobinopathies were diagnosed by the more sensitive method, High-Performance Liquid Chromatography (HPLC) on the analyzer ADAMS A1C Model No. HA-8180T Arkray/Japan. Results: Out of 1464 cases, 1022 (69.8%) were normal, and 442 (30.1%) cases had abnormal haemoglobin pattern. 688(46.9%) were males and 776 (53.0%) were females. Out of 1022 cases of Anemia, 557 (54.5%) were microcytic hypochromic, 45(4.4%) macrocytic, and the rest 421(41.1%) had a normocytic normochromic picture. Of the total cases, 442 (30.1%) showed abnormal Hb fractions. The major abnormality observed was high HbA2. Other hemoglobinopathies in descending order of frequency were Hb D Disease at 40 (9.0%), sickle cell disease at 29 (6.5%), Hb E at 18(4.0%), Sickle/beta-thalassemia in 06 (1.3%), and Hb C 01 (0.2%). Conclusion: Our study revealed a higher frequency of the Beta Thalassaemia trait. It is suggested that detection of HbA2 should be carried out in all the high-risk groups with anaemia. Further larger studies are needed to screen our population to detect thalassaemia carrier state and Iron deficiency Anaemia.
Downloads
References
Rao S, Kar R, Gupta S K, Chopra A, Saxena R. Spectrum of hemoglobinopathies diagnosed by cation exchange HPLC & modulating effects of nutritional deficiency anaemias from north India. 2012; 132: 513-19.
https://doi.org/10.4103/0971-5916.73390
Sachdev R, Dam AR, Tyagi G. Detection of Hb variants and hemoglobinopathies in Indian population using HPLC: Report of 2600 cases. Ind J Pathol Microbiol. 2010; 53:57-62.
https://doi.org/10.4103/0377-4929.59185
National Heart, Lung, and Blood Institute: Thalassemias. 2012
4.GBD 2015 Disease and Injury Incidence and Prevalence Collaborators: Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016, 388:1545-602.
https://doi.org/10.1016/S0140-6736(16)31678-6
GBD 2015 Mortality and Causes of Death Collaborators: Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016, 388:1459-544.
https://doi.org/10.1016/S0140-6736(16)31012-1
Ehsan H, Wahab A, Answer F, Iftikhar R, Yousaf MN. Prevalence of transfusion transmissible infections in beta-thalassemia major patients in Pakistan: a Systematic Review. Cureus. 2020;12(8)e10070.
https://doi.org/10.7759/cureus.10070
Study of hemoglobinopathies in patients of anemia using high performance liquid chromatography (HPLC) in Western India. Natl J Community Med.2015; 6(1):35-40. Patel U, Shrivastav A, Joshi J R, Agnihotri A S, Kaur A, Thakkar
https://doi.org/10.4103/1658-5127.123308
Detection of hemoglobinopathies and thalassemias in population of Gujarat state using HPLC: Analysis of 2022 cases.Natl J Community Med. 2012; 4(2): 80-84.
Piel FB. The present and future global burden of the inherited disorders of hemoglobin. Hematol Oncol Clin. 2016; 30(2): 327-341.
https://doi.org/10.1016/j.hoc.2015.11.004
Payandeh M, Rahimi Z, Zare ME, Kansestani AN, Gohardehi F, Hashemian AH. The prevalence of anemia and hemoglobinopathies in the hematologic clinics of the kermanshah province, Western iran. Int J Hematol Oncol Stem Cell Res. 2014; 8(2): 33.
Brancaleoni V, Di Pierro E, Motta I, Cappelline MD. Laboratory diagnosis of thalassemia. Int J Lab Hematol 2016; 38(1): 32-40.
https://doi.org/10.1111/ijlh.12527
Qazi RA, Shams R, Hassan H, Asif N. Screening for Beta Thalassemia Trait. Journal of Rawalpindi Medical College (JRMC) 2014;18(1):158-60
Mirza A, Ghani A, Pal A, Sami A, Hannan S, Ashraf Z, et al. Thalassemia and premarital screening: potential for implementation of a screening program among young people in Pakistan. Haemoglobin 2013; 37(2):160-70.
14.Shabbir S, Nadeem M, Sattar A, Ara I, Ansari S, Farzana T, et al. Type and frequency of hemoglobinopathies, diagnosed in Karachi, Pakistan. Cogent Med. 2016;3(1):1188875.
https://doi.org/10.1080/2331205X.2016.1188875
Waheed U, Satti HS, Farooq N, Zaheer HA. Frequency of haemoglobinopathies: A single-centre, cross-sectional study from Islamabad, Pakistan. East Mediterr Health J. 2012;18(12):1257-1259.
https://doi.org/10.26719/2012.18.12.1257
Riaz H, Shah MA, Rehan G, Azeem R. Types, and frequency of hemoglobinopathies, diagnosed by HB electrophoreses in the lady reading hospital Peshawar, Pakistan. Khyber J Med Sci. 2020;13(1):39-42.
Salma RA, Saleh AK. Effectiveness of premarital screening program for thalassemia and sickle cell disorders in Ras Al Khaimah, United Arab Emirates. J Genet Med 2016;13(1): 26-30.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
